Association of CD40 ligand levels in the culprit coronary arteries with subsequent prognosis of acute myocardial infarction

Atherosclerosis

Volumn 213, Issue 1, 2010, Pages 268-272

  Yoshioka, Toru ^a   Funayama, Hiroshi ^a   Hoshino, Hirotaka ^a   Nakamura, Tomohiro ^a   Sugawara, Yoshitaka ^a   Kubo, Norifumi ^a   Nagata, Osamu ^a   Ako, Junya ^a   Ishikawa, San E ^a   Kawakami, Masanobu ^a   Momomura, Shin Ichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; CD40 ligand; Prognosis

Indexed keywords

CD40 LIGAND;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RIGHT CORONARY ARTERY;

ADULT; AGED; AGED, 80 AND OVER; AORTA; CD40 LIGAND; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBECTOMY;

EID: 77958451796     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.07.044     Document Type: Article

References (15)

1. Schönbeck U., Libby P. CD40 signaling and plaque instability. Circ Res 2001, 89:1092-1103.
2. Heeschen C., Dimmeler S., Hamm C.W., et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003, 348:1104-1111.
3. Antoniades C., Bakogiannis C., Tousoulis D., Antonopoulos A.S., Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 2009, 54:669-677.
4. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
5. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary arteries flow. Circulation 1996, 93:879-888.
6. Gibson C.M., Murphy S.A., Rizzo M.J., et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis in myocardial infarction (TIMI) study group. Circulation 1999, 99:1945-1950.
7. t'Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 1998, 97:2302-2306.
8. Lutgens E., Gorelik L., Daemen M.J., et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999, 5:1313-1316.
9. Mach F., Schönbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203.
10. Schönbeck U., Varo N., Libby P., Buring J., Ridker P.M. Soluble CD40L and cardiovascular risk in women. Circulation 2001, 104:2266-2268.
11. Varo N., de Lemos J.A., Libby P., et al. Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 2003, 108:1049-1052.
12. Aggarwal A., Schneider D.J., Terrien E.F., Sobel B.E., Dauerman H.L. Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques. Am J Cardiol 2004, 93:6-9.
13. Santilli F., Davì G., Consoli A., Cipollone F. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. J Am Coll Cardiol 2006, 47:391-397.
14. Urbich C., Dernbach E., Aicher A., Zeiher A.M., Dimmeler S. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 2002, 106:981-986.
15. Rezkalla S.H., Kloner R.A. No-reflow phenomenon. Circulation 2002, 105:656-662.